Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
121.52
-4.33 (-3.44%)
Nov 17, 2026, 4:00 PM EST - Market closed

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $102.24M in the twelve months ending September 30, 2026, up 133.77% year-over-year. In the year 2025, Kymera Therapeutics had annual revenue of $39.21M, down -16.70%. That makes Kymera Therapeutics the 22,543rd largest company in the world by revenue and 3,272nd in the United States.

Revenue (ttm)
$102.24M
Revenue Growth
+133.77%
P/S Ratio
101.48
Revenue / Employee
$358,719
Employees
285
Market Cap
10.37B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202539.21M-7.86M-16.70%
Dec 31, 202447.07M-31.52M-40.11%
Dec 31, 202378.59M31.77M67.84%
Dec 31, 202246.83M-26.01M-35.71%
Dec 31, 202172.83M38.80M114.00%
Dec 31, 202034.03M31.10M1,059.99%
Dec 31, 20192.93M--
Dec 31, 20182.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.